Scheme 1a
a Reagents and conditions: (a) (i) ClSO2NCO, CH2Cl2, 0 °C; (ii) amino ester, Et3N, CH2Cl2, 82-96%. (b) 5 mol %
(IMesH2)(PCy3)(Cl)2RudCHPh, CH2Cl2, reflux. (c) Allyl bromide, K2CO3, NaI, DMF, 50 °C. (d) (i) Cinnamyl alcohol, PPh3, DIAD, THF,
rt; (ii) 5 mol % (IMesH2)(PCy3)(Cl)2RudCHPh, CH2Cl2, reflux; (iii) EtOCHdCH2; (iv) MeOH and then filter. (e) 10 mol %
(PCy3)2(Cl)2RudCHPh, CH2Cl2, 50 °C. (f) 1:1 TFA/CH2Cl2, 49-53% over four steps.
oligomers as soluble supports for a multistep synthesis to
produce a series of unsymmetric sulfamide peptidomimetics.
The utility of ROM supports in combinatorial chemistry
was first reported by Barrett and co-workers through the
development of ROMPgel reagents6 and an “impurity anni-
hilation” reagent.7 Recently, Enholm has used ROM oligo-
mers as soluble supports for single-step free radical reac-
tions.5 We have since reported the use of capture-ROMP-
release8 and ROMP scavenging9 as alternative ROMP-based
techniques that exploit organic-soluble polymers.
We have recently reported the synthesis and ROM
polymerization of various amino acid-derived sulfonamide
monomers.10 During the course of this work, we envisioned
that norbornenyl-functionalized substrates could provide a
manifold for accomplishing (1) functional group protection
via a norbornenyl-tagged Wang-like protecting group (NWPG);
(2) phase-trafficking purification; (3) mid-stage morphing
of synthesis onto soluble supports; and (4) Wang-sensitive
TFA release of final products. This 4-fold utilization of nor-
bornenyl-tagged chemistry is termed ring-opening metathesis
phase-trafficking11 (ROMpt). After each step, the ROM
oligomer is isolated from reaction impurities, simply by
precipitation with a suitable agent, i.e., one that reaction
impurities are soluble in. Once isolated, the oligomers can
be redissolved in typical reaction solvents to allow further
functionalization. This paper describes our initial results of
this 4-fold ROMpt strategy.
We initially chose to apply monomer 112,13 (Scheme 1) to
our reported synthesis of cyclic sulfamide peptidomimetics.14
NWPG 1 was reacted with chlorosulfonyl isocyanate fol-
lowed by coupling with valine methyl ester. The NWPG-
protected sulfamoyl carbamate 2b was then polymerized with
5 mol % (IMesH2)(PCy3)(Cl)2RudCHPh. Unfortunately, the
resulting oligomer (20-mer of 2) was not soluble in CH2Cl2.
However, it was sufficiently soluble in DMF to allow for
subsequent bis-allylation resulting in the production of 4e,
which was isolated by precipitation with water in order to
remove the DMF and inorganic salts. The CH2Cl2-soluble
oligomer 4e was then treated with 10 mol % Grubbs
benzylidene catalyst to produce 5b. Cyclic sulfamide 6b was
then cleaved from the support with 1:1 TFA/CH2Cl2. While
we were pleased with the success of this ROM-supported
RCM sequence, we felt that the narrow solubility profile of
the oligomer produced from 2b warranted a change in
strategy. We felt that employing a Mitsunobu reaction and
a subsequent ROMP-mediated phase-trafficking purification
would allow the Mitsunobu products to be formed and
isolated on the ROM-polymer phase, thus avoiding the
generation of an oligomer containing two hydrogen bond
donors. Additionally, in order to carry out such a protocol,
it would be necessary to utilize a phenyl-protected olefin,
which we have previously shown to be compatible with
ROM polymerization protocols.8
To this end (Scheme 1), sulfamoyl carbamates 2 were
reacted with cinnamyl alcohol under Mitsunobu conditions.
The norbornenyl-tagged products were then induced to
undergo phase-trafficking purification by in situ polymeri-
(5) (a) Enholm, E. J.; Gallagher, M. E. Org. Lett. 2001, 3, 3397-3399.
(b) Enholm, E. J.; Cottone, J. S. Org. Lett. 2001, 3, 3959-3962.
(6) Review: Barrett, A. G. M.; Hopkins, B. T.; Ko¨bberling, J. Chem.
ReV. 2002, 102, 3301-3324.
(7) Barrett, A. G. M.; Roberts, R. S.; Schro¨der, J. Org. Lett. 2000, 2,
2999-3001.
(12) Monomer (()-1 was prepared as an ∼8:1 mixture of endo/exo
diastereomers that were carried through as a mixture for ease of use.
(13) Monomer (()-1 is prepared on a multigram scale in five steps from
styrene sulfonyl chloride. The only chromatography required in this synthesis
is the removal of dicyclopentadiene from the Diels-Alder adduct and the
removal of any aluminum salts from 1. In both cases, the careful collection
of fractions is not necessary. For more details, see Supporting Information.
(14) Dougherty, J. M.; Probst, D. A.; Robinson, R. E.; Moore, J. D.;
Klein, T. A.; Snelgrove, K. A.; Hanson, P. R. Tetrahedron 2000, 56, 9781-
9790.
(8) Harned, A. M.; Hanson, P. R. Org. Lett. 2002, 4, 1007-1010.
(9) Moore, J. D.; Harned, A. M.; Henle, J.; Flynn, D. L.; Hanson, P. R.
Org. Lett. 2002, 4, 1847-1849.
(10) Wanner, J.; Harned, A. M.; Probst, D. A.; Poon, K. W. C.; Klein,
T. A.; Snelgrove, K. A.; Hanson, P. R. Tetrahedron Lett. 2002, 43, 917-
921.
(11) For a review on phase-trafficking, see: Flynn, D. L. Med. Res. ReV.
1999, 19, 408-431.
16
Org. Lett., Vol. 5, No. 1, 2003